PRIMARY OBJECTIVE(S):~- Determine the sensitivity and specificity of 89Zr-panitumumab for the detection of suspected metastatic lesions~SECONDARY OBJECTIVE(S):~- Compare sensitivity and specificity of 18F-FDG-PET/CT and 89Zr-panitumumab-PET/CT for detection of suspected metastatic lesions
The purpose of this study is to determine the diagnostic utility of 89Zr-panitumumab to identify metastatic lesion(s) in subjects with head and neck squamous cell carcinoma (HNSCC).